This article was originally published in The Gray Sheet
FDA's Devices and Biologics Centers will host a workshop in conjunction with the American National Red Cross to discuss scientific issues surrounding the use of plasticizers in blood collection, storage and transfusion. The meeting will take place Oct. 18 in the Warren Grant Magnuson Clinical Center at the National Institutes of Health in Bethesda, Maryland. Goals of the workshop include reviewing the effects of leachable plasticizers in the storage containers of blood products, examining the availability, efficacy and toxicity of alternative plasticizers, and discussing the risk assessment process used in recent evaluations of the toxicity of phthalate plasticizers. Registration is recommended before Oct. 4
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.